Identifying genomic rearrangements in BRCA1 and BRCA2 in high-risk individuals for hereditary breast and ovarian cancer von Jackson, M., Mattair, D., Lin, H., Gutierrez-Barrera, A. M., Elsayegh, N., Litton, J. K., Hortobagyi, G. N., Arun, B.

Volltext

Outcomes of children exposed to chemotherapy in utero for breast cancer von Litton, J. K., Hodge, S., Mattair, D., Ramirez, M. M., Morrow, P. K. H., Gonzalez-Angulo, A. M., Barnett, C. M., Hortobagyi, G. N., Theriault, R. L.

Volltext

P2-13-05: Breast Cancer, BRCA Mutations and Attitudes Regarding Pregnancy and Preimplantation Genetic Diagnosis von Litton, JK, Etzel, CJ, Jackson, MA, Muse, KI, Turco, D, Schover, LR, Theriault, RL, Mattair, D, Lu, KH, Hortobagyi, GN, Arun, BK

Volltext

Gene-signature-based patient selection for dasatinib therapy in metastatic breast cancer (MBC) von Pusztai, L., Moulder, S. L., Litton, J. K., Valero, V., Ueno, N. T., Morrow, P. H., Dotter, K., Mattair, D., Strauss, L. C., Symmans, W. F.

Volltext

Abstract P6-14-06: Prospective Testing of Three Different Gene-Signatures for Patient Selection for Dasatinib Therapy in Metastatic Breast Cancer von Pusztai, L, Moulder, S, Litton, J, Valero, V, Ueno, N, Melhem-Bertrandt, A, Morrow, PK, Dotter, K, Mattair, D, Strauss, L, Hortobagyi, GN, Qi, Y, Symmans, WF

Volltext